Intravenous tPA Administration in Patients With Acute Ischemic Stroke: Edirne ExperienceASL, TalipBALCI, KemalUTKU, UfukR, NasfJournal of Neurological Sciences
5,6,7 The only pharmacologic therapy approved by the US Food and Drug Administration for acute ischemic stroke remains tissue plasminogen activator (tPA). However, its use is limited because current guidelines indicate it must be administered within 4.5 hours of stroke onset. This restriction is ...
Another approach, stroke specialists say, is to direct all patients with stroke symptoms to designated stroke centers. There, stroke patients would be treated by experienced neurologists and admitted to stroke units for additional care. For the first time, in its newly published guidelines, the Ame...
Objectives To assess time trends in intravenous thrombolytic (iv tPA) treatment in a general local hospital during a period with organizational changes, especially how movement of treatment start from the emergency room (ER) to the CT laboratory, and changing method of administration of acute antihyp...
She is a candidate to receive endovascular therapy (EVT) based on your institution’s current guidelines, but she is also within the current window for the administration of tissue plasminogen activator (tPA). Clinical Question Should you give tPA while waiting for your neurointerventional team ...
I'm Lt. Tu from the US Food and Drug Administration (FDA) Division of Medication Error Prevention and Analysis. The purpose of this video is to talk about medication error reports associated with Activase® and TNKase® due to the use of the abbreviations "tPA" and "TNK." Activase, ...
A meta‐analysis on racial disparity in administration of tissue plasminogen activator (tPA) in stroke patientsdoi:10.1002/hsr2.2181Larik, Muhammad OmarBhattarai, PratikHealth Science Reports
Administration of tissue plasminogen activator (tPA) during first 3-4.5h after ischemic stroke is the main therapeutic strategy; however, its using after that, leads to reperfusion injury and neurotoxic effects. Additionally, inflammation has a critical role in secondary injury after late reperfusion ...
Administration of tissue plasminogen activator (tPA) during first 3–4.5 h after ischemic stroke is the main therapeutic strategy; however, its using after that, leads to reperfusion injury and...doi:10.1007/s10753-018-0848-xRahmani Mohammad-Reza...
Abstract W P212: The Effect Of Pre-hospital Notification On Time To Head Ct, Stroke Specialist Arrival, And Tpa Administration For Hispanic Patients With Acute StrokeAcute stroke careEmergency careHealth services researchHealth policyBackground: Hispanics have an increased incide...